E3 Ligase FLRF (Rnf41) Regulates Differentiation of Hematopoietic Progenitors by Governing Steady-state Levels of Cytokine and Retinoic Acid Receptors

Overview

Journal Exp Hematol

Specialty Hematology

Date 2008 May 23

PMID 18495327

Citations 20

Authors

Xin Jing

Jorge Infante

Ronald G Nachtman

Roland Jurecic

Affiliations

Soon will be listed here.

Abstract

Objective: FLRF (Rnf41) gene was identified through screening of subtracted cDNA libraries form murine hematopoietic stem cells and progenitors. Subsequent work has revealed that FLRF acts as E3 ubiquitin ligase, and that it regulates steady-state levels of neuregulin receptor ErbB3 and participates in degradation of IAP protein BRUCE and parkin. The objective of this study was to start exploring the role of FLRF during hematopoiesis.

Materials And Methods: FLRF was overexpressed in a murine multipotent hematopoietic progenitor cell line EML, which can differentiate into almost all blood cell lineages, and in pro-B progenitor cell line BaF3. The impact of FLRF overexpression on EML cell differentiation into myeloerythroid lineages was studied using hematopoietic colony-forming assays. The interaction of FLRF with cytokine receptors and receptor levels in control cells and EML and BaF3 cells overexpressing FLRF were examined with Western and immunoprecipitation.

Results: Remarkably, overexpression of FLRF significantly attenuated erythroid and myeloid differentiation of EML cells in response to cytokines erythropoietin (EPO) and interleukin-3 (IL-3), and retinoic acid (RA), and resulted in significant and constitutive decrease of steady-state levels of IL-3, EPO, and RA receptor-alpha (RARalpha) in EML and BaF3 cells. Immunoprecipitation has revealed that FLRF interacts with IL-3, EPO, and RARalpha receptors in EML and BaF3 cells, and that FLRF-mediated downregulation of these receptors is ligand binding-independent.

Conclusions: The results of this study have revealed new FLRF-mediated pathway for ligand-independent receptor level regulation, and support the notion that through maintaining basal levels of cytokine receptors, FLRF is involved in the control of hematopoietic progenitor cell differentiation into myeloerythroid lineages.

Citing Articles

E3 ubiquitin ligase on the biological properties of hematopoietic stem cell.

Zhan Q, Wang J, Zhang H, Zhang L J Mol Med (Berl). 2023; 101(5):543-556.

PMID: 37081103 PMC: 10163092. DOI: 10.1007/s00109-023-02315-6.

RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells.

Tullett K, Tan P, Park H, Schittenhelm R, Michael N, Li R Elife. 2020; 9.

PMID: 33264090 PMC: 7710356. DOI: 10.7554/eLife.63452.

CACYBP Enhances Cytoplasmic Retention of P27 to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation.

Lian Y, Huang Y, Zhang Y, Chen D, Wang J, Wei H Theranostics. 2019; 9(26):8392-8408.

PMID: 31754404 PMC: 6857042. DOI: 10.7150/thno.36838.

The ubiquitin ligase HECTD1 promotes retinoic acid signaling required for development of the aortic arch.

Sugrue K, Sarkar A, Leatherbury L, Zohn I Dis Model Mech. 2018; 12(1).

PMID: 30578278 PMC: 6361158. DOI: 10.1242/dmm.036491.

Erythropoietin Receptor Signaling and Lipid Rafts.

McGraw K, List A Vitam Horm. 2017; 105:79-100.

PMID: 28629526 PMC: 7771362. DOI: 10.1016/bs.vh.2017.02.002.

References

Chen C, Sytkowski A . Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism. Blood. 2004; 104(1):73-80. DOI: 10.1182/blood-2003-04-1340. View

Metcalf D . Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors. Proc Natl Acad Sci U S A. 1991; 88(24):11310-4. PMC: 53124. DOI: 10.1073/pnas.88.24.11310. View

Joazeiro C, Weissman A . RING finger proteins: mediators of ubiquitin ligase activity. Cell. 2000; 102(5):549-52. DOI: 10.1016/s0092-8674(00)00077-5. View

Tsai S, Bartelmez S, Sitnicka E, Collins S . Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev. 1994; 8(23):2831-41. DOI: 10.1101/gad.8.23.2831. View

Du Y, Campbell J, Nalbant D, Youn H, Bass A, Cobos E . Mapping gene expression patterns during myeloid differentiation using the EML hematopoietic progenitor cell line. Exp Hematol. 2002; 30(7):649-58. DOI: 10.1016/s0301-472x(02)00817-2. View

Si J, Collins S . IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner. Blood. 2002; 100(13):4401-9. DOI: 10.1182/blood-2001-12-0374. View

Jackson P, Eldridge A, Freed E, Furstenthal L, Hsu J, Kaiser B . The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 2000; 10(10):429-39. DOI: 10.1016/s0962-8924(00)01834-1. View

Alexander W, Hilton D . The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol. 2004; 22:503-29. DOI: 10.1146/annurev.immunol.22.091003.090312. View

Christensen J, Weissman I . Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A. 2001; 98(25):14541-6. PMC: 64718. DOI: 10.1073/pnas.261562798. View

10.

Ben-Neriah Y . Regulatory functions of ubiquitination in the immune system. Nat Immunol. 2001; 3(1):20-6. DOI: 10.1038/ni0102-20. View

11.

Qiu X, Markant S, Yuan J, Goldberg A . Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. EMBO J. 2004; 23(4):800-10. PMC: 380992. DOI: 10.1038/sj.emboj.7600075. View

12.

Yasukawa H, Sasaki A, Yoshimura A . Negative regulation of cytokine signaling pathways. Annu Rev Immunol. 2000; 18:143-64. DOI: 10.1146/annurev.immunol.18.1.143. View

13.

Lawson N, Krause D, Berliner N . Normal neutrophil differentiation and secondary granule gene expression in the EML and MPRO cell lines. Exp Hematol. 1998; 26(12):1178-85. View

14.

Bourette R, De Sepulveda P, Arnaud S, Dubreuil P, Rottapel R, Mouchiroud G . Suppressor of cytokine signaling 1 interacts with the macrophage colony-stimulating factor receptor and negatively regulates its proliferation signal. J Biol Chem. 2001; 276(25):22133-9. DOI: 10.1074/jbc.M101878200. View

15.

Fanelli M, Minucci S, Gelmetti V, Nervi C, Gambacorti-Passerini C, Pelicci P . Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance. Blood. 1999; 93(5):1477-81. View

16.

Abdullah J, Li X, Nachtman R, Jurecic R . FLRF, a novel evolutionarily conserved RING finger gene, is differentially expressed in mouse fetal and adult hematopoietic stem cells and progenitors. Blood Cells Mol Dis. 2001; 27(1):320-33. DOI: 10.1006/bcmd.2001.0390. View

17.

Viswanathan S, Benatar T, Rose-John S, Lauffenburger D, Zandstra P . Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6. Stem Cells. 2002; 20(2):119-38. DOI: 10.1634/stemcells.20-2-119. View

18.

Rubin C, Gur G, Yarden Y . Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation. Cell Res. 2005; 15(1):66-71. DOI: 10.1038/sj.cr.7290268. View

19.

Pawlak G, Grasset M, Arnaud S, Blanchet J, Mouchiroud G . Receptor for macrophage colony-stimulating factor transduces a signal decreasing erythroid potential in the multipotent hematopoietic EML cell line. Exp Hematol. 2000; 28(10):1164-73. DOI: 10.1016/s0301-472x(00)00522-1. View

20.

Tsai S . Differential effects of c-fms and c-kit ligands on the lineage development of the lymphohematopoietic cell line EML C1. Cancer Chemother Pharmacol. 1996; 38 Suppl:S58-63. DOI: 10.1007/s002800051040. View